Some clinical trials and evolutions of potential vaccines, therapies, and diagnostics for Ebola virus disease are being carried out. However, a range of potential treatments including blood products, immune therapies and drug therapies are currently being evaluated. When a vaccine and drug is not approved, the FDA can authorize access to potentially promising drugs through other means .The following mechanism are as such, individual-patient or open-label expanded access investigational IND (Investigation New Drug). For such experimental treatment to be registered in USA . Certain criteria should be met and a request should be submitted and the request should be authorized by FDA.